These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37776921)

  • 1. Yeast glucan particles: An express train for oral targeted drug delivery systems.
    Yang F; Shang S; Qi M; Xiang Y; Wang L; Wang X; Lin T; Hao D; Chen J; Liu J; Wu Q
    Int J Biol Macromol; 2023 Dec; 253(Pt 5):127131. PubMed ID: 37776921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired yeast-based β-glucan system for oral drug delivery.
    Wu Y; Li P; Jiang Z; Sun X; He H; Yan P; Xu Y; Liu Y
    Carbohydr Polym; 2023 Nov; 319():121163. PubMed ID: 37567689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Strategy for Treating Inflammatory Bowel Disease by Targeting Delivery of Methotrexate through Glucan Particles.
    Sun Y; Duan B; Chen H; Xu X
    Adv Healthc Mater; 2020 Mar; 9(6):e1901805. PubMed ID: 32092235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists.
    Huang H; Ostroff GR; Lee CK; Wang JP; Specht CA; Levitz SM
    Infect Immun; 2009 May; 77(5):1774-81. PubMed ID: 19273561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Glucan-A promising immunocyte-targeting drug delivery vehicle: Superiority, applications and future prospects.
    He L; Zhu Z; Qi C
    Carbohydr Polym; 2024 Sep; 339():122252. PubMed ID: 38823919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of yeast cell wall glucan by Atlantic salmon (Salmo salar L.) macrophages.
    Engstad RE; Robertsen B
    Dev Comp Immunol; 1993; 17(4):319-30. PubMed ID: 8375567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specifically targeted delivery of protein to phagocytic macrophages.
    Yu M; Chen Z; Guo W; Wang J; Feng Y; Kong X; Hong Z
    Int J Nanomedicine; 2015; 10():1743-57. PubMed ID: 25784802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entrapping of Nanoparticles in Yeast Cell Wall Microparticles for Macrophage-Targeted Oral Delivery of Cabazitaxel.
    Ren T; Gou J; Sun W; Tao X; Tan X; Wang P; Zhang Y; He H; Yin T; Tang X
    Mol Pharm; 2018 Jul; 15(7):2870-2882. PubMed ID: 29863879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation.
    Huang J; Wu C; Tang S; Zhou P; Deng J; Zhang Z; Wang Y; Wang Z
    Int J Nanomedicine; 2020; 15():5083-5095. PubMed ID: 32764938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid content of microparticulate (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae.
    Müller A; Mayberry W; Acuff R; Thedford S; Browder W; Williams D
    Microbios; 1994; 79(321):253-61. PubMed ID: 7837997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-d-glucan-based drug delivery system and its potential application in targeting tumor associated macrophages.
    Su Y; Chen L; Yang F; Cheung PCK
    Carbohydr Polym; 2021 Feb; 253():117258. PubMed ID: 33278940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulation of poorly soluble drugs in yeast glucan particles by spray drying improves dispersion and dissolution properties.
    Ruphuy G; Saloň I; Tomas J; Šalamúnová P; Hanuš J; Štěpánek F
    Int J Pharm; 2020 Feb; 576():118990. PubMed ID: 31899318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yeast glucan particles enable intracellular protein delivery in Drosophila without compromising the immune system.
    Bajgar A; Saloň I; Krejčová G; DoleŽal T; Jindra M; Štěpánek F
    Biomater Sci; 2019 Nov; 7(11):4708-4719. PubMed ID: 31565713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-Glucan Particles as Vaccine Adjuvant Carriers.
    Mirza Z; Soto ER; Dikengil F; Levitz SM; Ostroff GR
    Methods Mol Biol; 2017; 1625():143-157. PubMed ID: 28584989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of β-glucan particles as dual-function carriers for poorly soluble drugs.
    Šalamúnová P; Saloň I; Ruphuy G; Kroupová J; Balouch M; Hanuš J; Štěpánek F
    Eur J Pharm Biopharm; 2021 Nov; 168():15-25. PubMed ID: 34411641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and lymph pharmacokinetics of nilotinib delivered by yeast glucan particles per os.
    Šalamúnová P; Krejčí T; Ryšánek P; Saloň I; Kroupová J; Hubatová-Vacková A; Petřík J; Grus T; Lukáč P; Kozlík P; Křížek T; Dammer O; Beránek J; Šíma M; Slanař O; Štěpánek F
    Int J Pharm; 2023 Mar; 634():122627. PubMed ID: 36693484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of NK007 to macrophages to treat colitis.
    Chen S; Wang J; Cheng H; Guo W; Yu M; Zhao Q; Wu Z; Zhao L; Yin Z; Hong Z
    J Pharm Sci; 2015 Jul; 104(7):2276-84. PubMed ID: 25964181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in oral vaccine development: yeast-derived β-glucan particles.
    De Smet R; Allais L; Cuvelier CA
    Hum Vaccin Immunother; 2014; 10(5):1309-18. PubMed ID: 24553259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype.
    Liu M; Luo F; Ding C; Albeituni S; Hu X; Ma Y; Cai Y; McNally L; Sanders MA; Jain D; Kloecker G; Bousamra M; Zhang HG; Higashi RM; Lane AN; Fan TW; Yan J
    J Immunol; 2015 Nov; 195(10):5055-65. PubMed ID: 26453753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic Yeast Glucan Particles for Antibody-Free Separation of Viable Macrophages from
    Krejčová G; Saloň I; Klimša V; Ulbrich P; Aysan AB; Bajgar A; Štěpánek F
    ACS Biomater Sci Eng; 2024 Jan; 10(1):355-364. PubMed ID: 38048070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.